瘤微环境中的维门:编排入侵,免疫和新陈代谢
Sepideh Parvanian1, John E Eriksson2
1Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA 02114, USA; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku 20520, Finland.
European journal of cell biology
|November 27, 2025
概括
维门是瘤微环境 (TME) 中的关键蛋白质,调节细胞行为并支持癌症的进展. 向维门丁为改善癌症治疗结果提供了潜在的新策略.
科学领域:
- 细胞生物学 细胞生物学
- 癌症生物学 癌症生物学
- 生物化学 生物化学
背景情况:
- 维门是一种III型中间丝蛋白,越来越多地被认为具有多方面的作用,超出了表皮细胞转化为介质细胞转化 (EMT) 的标志物.
- 它作为一个关键的结构和信号枢纽,将细胞骨动态与细胞过程相结合.
- 维门的功能对于各种细胞类型的可塑性和适应性行为至关重要,包括瘤微环境中的细胞.
研究的目的:
- 在瘤微环境 (TME) 中提供维门丁多样化功能的综合概述.
- 突出维门丁对癌症关键特征的贡献,如侵入性,免疫调节和代谢适应.
- 探索以维门丁为中心的治疗策略在癌症治疗中的潜力.
主要方法:
- 本综述综合了关于维门丁在TME中的作用的现有研究.
- 它整合了关于细胞骨架构,信号网络和细胞可塑性的研究结果.
- 该审查侧重于维门丁在癌症中的机械传导,免疫逃避和代谢重编程中的参与.
主要成果:
- 维门对于癌细胞的迁移,重塑和适应能力至关重要.
- 它的表达在侵袭性癌症中是普遍存在的,在那里它支架和协调恶性瘤的关键细胞重新连接.
- 维门显著影响瘤的侵入性,免疫逃避和TME内的代谢适应.
结论:
- 维丁是一种多功能调节剂,对癌细胞存活,进展和适应在TME中至关重要.
- 了解维门的复杂作用为开发新型治疗方法提供了基础.
- 向维门丁为改善各种癌症治疗结果提供了一个有希望的途径.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


